|
業務類別
|
-- |
|
業務概覽
|
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPintherapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment. |
| 公司地址
| Wagistrasse 14, Schlieren, Zurich, CHE, 8952 |
| 電話號碼
| +41 447557700 |
| 傳真號碼
| +41 447557707 |
| 公司網頁
| https://www.molecularpartners.com |
| 員工數量
| 159 |
| Mr. Alexander Zurcher |
Chief Operating Officer |
-- |
06/03/2025 |
| Ms. Renate Gloggner |
Executive Vice President, People and Community |
-- |
06/03/2025 |
| Dr. Philippe Legenne |
Chief Medical Officer |
-- |
06/03/2025 |
| Dr. Patrick Amstutz, PhD |
Chief Executive Officer and Director |
瑞郎 385.00K |
06/03/2025 |
| Dr. Michael Tobias Stumpp, PhD |
Executive Vice President, Projects |
-- |
06/03/2025 |
|
|
| Mr. Steven H. Holtzman |
Independent Director |
06/03/2025 |
| Dr. Vito J. Palombella, PhD |
Independent Director |
06/03/2025 |
| Mr. William M. Burns |
Chairman of the Board |
06/03/2025 |
| Mr. Sandip S. Kapadia, C.P.A.,M.B.A. |
Independent Director |
06/03/2025 |
| Dr. Michael J. Vasconcelles, M.D. |
Independent Director |
06/03/2025 |
| Dr. Patrick Amstutz, PhD |
Chief Executive Officer and Director |
06/03/2025 |
| Dr. Agnete Fredriksen, PhD |
Independent Director |
06/03/2025 |
| Dr. Dominik Hochli, M.D. |
Independent Director |
06/03/2025 |
|
|
|
|
